Home Stepwise strategies in analysing haematuria and leukocyturia in screening
Article
Licensed
Unlicensed Requires Authentication

Stepwise strategies in analysing haematuria and leukocyturia in screening

  • Josiane Steinmetz , Joseph Henny and René Gueguen
Published/Copyright: April 7, 2006

Abstract

The aim of the present work was to compare in a supposed healthy population of 680 subjects several algorithms for positive selection of urine samples requiring microscopic examination for erythrocytes and leukocytes after screening by automated test-strip measurement and particle counting on a Sysmex UF-50™ flow cytometer. Four strategies have been formulated and the sensitivity, specificity, positive predictive value, negative predictive value, false positive rate, false negative rate, and microscopic review rate were measured. The strategy combining test strip analysis and automated counting on all samples, followed by microscopic examination of only discordant samples gave the best results. When the two methods of haematuria screening were in agreement (91% of samples), the false negative rate for microscopy was 1.1%, with a false positive rate of 0.8%, sensitivity of 66% and specificity of 99%, and the results are acceptable without any other examination. When the two methods of haematuria screening were discrepant, visual microscopic analysis was necessary to obtain definitive results. For leukocyturia screening, 80% of results were in agreement by test strip and automatic sediment urinalysis, with only ten results considered as false negatives (1.8%) and four as false positives (0.7%). Agreement was good and the other criteria were good (sensitivity 79%, specificity 99%). On conflicting samples, there was no agreement between methods and microscopic analysis was essential. The benefit of such an algorithm would be optimisation of the workflow without any loss of sensitivity and specificity at the expense of a two-fold increase in cost.


Corresponding author: Josiane Steinmetz, Laboratoire de Biologie Clinique, Centre de Médecine Préventive, 2 Avenue du Doyen Parisot, 54500 Vandoeuvre les Nancy, France Phone: +33-3-83448720, Fax: +33-3-83448721,

References

1. Kouri T, Fogazzi G, Gant V, Hallander H, Hofmann W, Guder WG. European urinalysis guidelines. ECLM European Urinalysis Group. Scand J Clin Lab Invest 2000; 60(Suppl):231.10.1080/00365513.2000.12056993Search in Google Scholar

2. Fenili D, Pirovano B. The automation of sediment urinalysis using a new urine flow cytometer (UF-100™). Clin Chem Lab Med 1998; 36:909–17.10.1515/CCLM.1998.158Search in Google Scholar

3. Hannemann-Pohl K, Kampf SC. Automation of urine sediment examination: a comparison of the Sysmex UF-100 automated flow cytometer with routine manual diagnosis (microscopy, test strips, and bacterial culture). Clin Chem Lab Med 1999; 37:753–64.10.1515/CCLM.1999.116Search in Google Scholar

4. Zaman Z, Roggeman S, Cappelletti P, Ferrai G, Buxeda M, Barba N. Evaluation of Aution Max AX-4280 automated urine test-strip analyser. Clin Chem Lab Med 2001; 39:649–57.10.1515/CCLM.2001.106Search in Google Scholar

5. Steinmetz J, Henny J, Gueguen R. Etablissement de limites de référence des sédiments urinaires mesurés sur UF-50™ Sysmex. Ann Biol Clin 2004; 62:1–10.Search in Google Scholar

6. Delanghe JR, Kouri T, Huber AR, Hannemann-Pohl K, Guder WG, Lun A, et al. The role of automated urine particle flow cytometry in clinical practice. Clin Chim Acta 2000; 301:1–18.10.1016/S0009-8981(00)00342-9Search in Google Scholar

7. Langlois MR, Delanghe JR, Steyaert SR, Everaert KC, De Buyzere ML. Automated flow cytometry compared with an automated dipstick reader for urinalysis. Clin Chem 1999; 45:118–22.10.1093/clinchem/45.1.118Search in Google Scholar

8. Regeniter A, Haenni V, Risch L, Köchli HP, Colombo JP, Frei R, et al. Urine analysis performed by flow cytometry: reference range determination and comparison to morphological findings, dipstick chemistry and bacterial culture results – a multicenter study. Clin Nephrol 2001; 55:384–92.Search in Google Scholar

9. Ottiger C, Huber AR. Quantitative urine particle analysis: integrative approach for the optimal combination of automation with UF-100 and microscopic review with KOVA cell chamber. Clin Chem 2003; 49:617–23.10.1373/49.4.617Search in Google Scholar

10. Steinmetz J, Henny J, Gueguen R. Détermination urinaire du glucose, des proteines, du sang et des leucocytes avec l'analyseur automatique Aution Max AX-4280. Ann Biol Clin 2005; 63:619–26.Search in Google Scholar

11. National Committee for Clinical Laboratory Standards. Routine urinalysis and collection, transportation and preservation of urine specimens: approved guideline. NCCLS document GP 16-A. Wayne, PA: NCCLS, 1995:1–51.Search in Google Scholar

12. Boucaud-Maitre Y, Thoinet S, Fuhrmann C, Coronel B, Freney J. Evaluation des performances et de la praticabilité de l'automate de cytobactériologie Sysmex UF-100™ pour la prédiction de l'infection urinaire. Rev Fr Lab 2001; 338:75–81.10.1016/S0338-9898(01)80355-3Search in Google Scholar

13. Penders J, Fiers T, Delanghe JR. Quantitative evaluation of urinalysis test strips. Clin Chem 2002; 48:2236–41.10.1093/clinchem/48.12.2236Search in Google Scholar

14. Lun A, Ziebig R, Priem F, Filler G, Sinha P. Routine workflow for use of urine strip and urine flow cytometer UF-100 in the hospital laboratory. Clin Chem 1999; 45:1305–7.10.1093/clinchem/45.8.1305Search in Google Scholar

Received: 2005-9-1
Accepted: 2005-12-28
Published Online: 2006-4-7
Published in Print: 2006-4-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Natriuretic peptides and evidence-based quality specifications
  2. Preanalytical variability: the dark side of the moon in laboratory testing
  3. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
  4. Hepatorenal syndrome
  5. Modified Levey-Jennings charts for calculated laboratory tests
  6. Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study
  7. The exponentially weighted moving average (EWMA) rule compared with traditionally used quality control rules
  8. Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results: application to Fibrotest® and Actitest® scores
  9. Comparison of TEST 1 with SRS 100 and ICSH reference method for the measurement of the length of sedimentation reaction in blood
  10. Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays
  11. Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay
  12. Erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alanine
  13. Matrix metalloproteinases and their inhibitors in different acute stroke subtypes
  14. Pyrosequencing protocol requiring a unique biotinylated primer
  15. Detection of antibodies against 60-, 65- and 70-kDa heat shock proteins in paediatric patients with various disorders using Western blotting and ELISA
  16. Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-tandem mass spectrometry
  17. Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients
  18. Stepwise strategies in analysing haematuria and leukocyturia in screening
  19. Elevation of serum cerebral injury markers correlates with serum choline decline after coronary artery bypass grafting surgery
  20. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study
  21. Release of anandamide from blood cells
  22. Rapid decrease in plasma D-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients
  23. Evaluation of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatography/tandem mass spectrometry
  24. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases
  25. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens
  26. Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome
  27. The dilemma of invasive and non-invasive investigations for adult and paediatric non-alcoholic fatty liver disease: has the time come for a new biochemical marker?
  28. Is cystatin C a reliable renal marker in trauma?
  29. On the independence of intraindividual reference values
  30. Sixth International Symposium on Molecular Diagnostics, Graz, Austria, May 25-27, 2006
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.064/html
Scroll to top button